Dec 29, 2025 • GlobeNewswire
BEARISH
ALVO Investor News: If You Have Suffered Losses in Alvotech
The Rosen Law Firm is investigating potential securities claims against Alvotech (NASDAQ: ALVO) on behalf of investors who suffered losses. This investigation follows a November 2025 announcement that Alvotech received a complete response letter from the FDA regarding its Biologics License Application for AVT05, due to unresolved deficiencies at its manufacturing facility. Alvotech's stock subsequently dropped significantly.
Dec 29, 2025 • Quiver Quantitative
NEUTRAL
Alvotech Files Notification with CSSF Regarding Changes in Own Shares
Alvotech has filed a notification with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) concerning changes in its own shares, dated December 29, 2025. This filing demonstrates the company's commitment to regulatory compliance and transparency regarding its capital structure. While actively managing its capital can enhance shareholder value, the lack of detailed information on the changes could lead to investor speculation or uncertainty.
Dec 29, 2025 • Benzinga
SOMEWHAT-BEARISH
Why Bolt Projects Holdings Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
Bolt Projects Holdings Inc. shares surged over 28% in pre-market trading after the company announced preliminary fiscal 2025 results and updated its fiscal 2026 sales guidance, raising it from $9 million to $11 million. This report also highlights several other stocks exhibiting significant pre-market movements, both gains and losses, driven by various company-specific news and market dynamics. Key gainers include Republic Power Group Limited, Fitell Corp, Antelope Enterprise Holdings, and DigitalBridge Group, while losers include ECD Automotive Design, WF Holding, and Emerson Radio Corp.
Dec 28, 2025 • FOX 2
NEUTRAL
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO
Rosen Law Firm is investigating potential securities claims on behalf of Alvotech (NASDAQ: ALVO) investors. This stems from allegations that Alvotech issued materially misleading business information after receiving a complete response letter from the FDA for its Biologics License Application for AVT05, causing a significant drop in its stock price. Investors who purchased Alvotech securities are encouraged to contact Rosen Law Firm to inquire about joining a prospective class action.
Dec 28, 2025 • MarketBeat
SOMEWHAT-BEARISH
Alvotech (NASDAQ:ALVO) Short Interest Down 41.1% in December
Alvotech (NASDAQ:ALVO) experienced a significant decrease of 41.1% in short interest during December, totaling 1,885,572 shares as of December 15th. This reduction brings the days-to-cover ratio down to 3.1 days and means only 0.6% of the company's shares are currently sold short. Despite this, the company missed both quarterly EPS and revenue estimates, leading to mixed analyst ratings and an average price target of $8.60.
Dec 25, 2025 • NEWS10 ABC
BEARISH
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO
The Rosen Law Firm has announced an investigation into potential securities claims on behalf of Alvotech (NASDAQ: ALVO) shareholders. This follows allegations that Alvotech may have issued materially misleading business information, particularly after receiving a complete response letter (CRL) from the FDA regarding its Biologics License Application for AVT05 due to deficiencies at its manufacturing facility. The firm is preparing a class action lawsuit seeking to recover investor losses after Alvotech's stock price significantly dropped following this news.